Upstream Bio, Inc. · NASDAQ:UPB
Upstream Bio, Inc. shareholders
As of Sep 30, 2026, 131 institutions reported holding Upstream Bio, Inc., 87.7% of its shares. Largest: Fidelity, Orbimed Advisors LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Upstream Bio, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 8.18M | 14.9% | +18,689 | Nov 10, 2026 |
| Orbimed Advisors LLC | 5.69M | 10.4% | no change | Nov 16, 2026 |
| BlackRock | 3.69M | 6.7% | −66,048 | Nov 13, 2026 |
| Vanguard | 3M | 5.5% | +156K | Nov 13, 2026 |
| Decheng Capital LLC | 2.72M | 5.0% | no change | Nov 13, 2026 |
| Enavate Sciences Gp, LLC | 2.46M | 4.5% | no change | Nov 16, 2026 |
| JPMorgan | 1.46M | 2.7% | +447K | Nov 12, 2026 |
| D. E. Shaw & Co., Inc. | 1.4M | 2.6% | +363K | Nov 16, 2026 |
| Millennium | 1.17M | 2.1% | +24,406 | Nov 16, 2026 |
| Goldman Sachs | 1.13M | 2.1% | +880K | Nov 16, 2026 |